Artiklar med krav på offentlig åtkomst - Carolyn SueLäs mer
Inte tillgängliga någonstans: 19
The pathogenesis of Parkinson's disease
HR Morris, MG Spillantini, CM Sue, CH Williams-Gray
The Lancet 403 (10423), 293-304, 2024
Krav: UK Medical Research Council, National Institute for Health Research, UK …
The role of ATP13A2 in Parkinson's disease: clinical phenotypes and molecular mechanisms
JS Park, NF Blair, CM Sue
Movement Disorders 30 (6), 770-779, 2015
Krav: National Health and Medical Research Council, Australia
ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome
A Grünewald, B Arns, P Seibler, A Rakovic, A Münchau, A Ramirez, ...
Neurobiology of aging 33 (8), 1843. e1-1843. e7, 2012
Krav: German Research Foundation
Pathogenic effects of novel mutations in the P‐type ATPase ATP13A2 (PARK9) causing Kufor‐Rakeb syndrome, a form of early‐onset parkinsonism
JS Park, P Mehta, AA Cooper, D Veivers, A Heimbach, B Stiller, ...
Human mutation 32 (8), 956-964, 2011
Krav: German Research Foundation
Two Australian families with inclusion-body myopathy, Paget’s disease of bone and frontotemporal dementia: novel clinical and genetic findings
KR Kumar, M Needham, K Mina, M Davis, J Brewer, C Staples, K Ng, ...
Neuromuscular Disorders 20 (5), 330-334, 2010
Krav: US National Institutes of Health
Olfactory impairment in older adults is associated with poorer diet quality over 5 years
B Gopinath, J Russell, CM Sue, VM Flood, G Burlutsky, P Mitchell
European journal of nutrition 55, 1081-1087, 2016
Krav: National Health and Medical Research Council, Australia
POLG mutations in Australian patients with mitochondrial disease
P Woodbridge, C Liang, RL Davis, H Vandebona, CM Sue
Internal medicine journal 43 (2), 150-156, 2013
Krav: National Health and Medical Research Council, Australia
The gut microbiota: a novel therapeutic target in Parkinson's disease?
M Lubomski, RL Davis, CM Sue
Parkinsonism & related disorders 66, 265-266, 2019
Krav: National Health and Medical Research Council, Australia
High degree of genetic heterogeneity for hereditary cerebellar ataxias in Australia
C Kang, C Liang, KE Ahmad, Y Gu, SF Siow, JG Colebatch, S Whyte, ...
The Cerebellum 18, 137-146, 2019
Krav: National Health and Medical Research Council, Australia
Loss of ATP13A2 impairs glycolytic function in Kufor-Rakeb syndrome patient-derived cell models
JS Park, B Koentjoro, RL Davis, CM Sue
Parkinsonism & related disorders 27, 67-73, 2016
Krav: National Health and Medical Research Council, Australia
Phenotypic variability of parkin mutations in single kindred
B Koentjoro, JS Park, AD Ha, CM Sue
Movement disorders 27 (10), 1299-1303, 2012
Krav: National Health and Medical Research Council, Australia, Government of Spain
SPAST mutations in Australian patients with hereditary spastic paraplegia
H Vandebona, NP Kerr, C Liang, CM Sue
Internal medicine journal 42 (12), 1342-1347, 2012
Krav: National Health and Medical Research Council, Australia
A novel homozygous mutation in the FUCA1 gene highlighting fucosidosis as a cause of dystonia: Case report and literature review
G Wali, GM Wali, CM Sue, KR Kumar
Neuropediatrics 50 (04), 248-252, 2019
Krav: National Health and Medical Research Council, Australia, Medical Research …
Peripheral neuropathy in hereditary spastic paraplegia due to spastin (SPG4) mutation–a neurophysiological study using excitability techniques
KR Kumar, CM Sue, D Burke, K Ng
Clinical neurophysiology 123 (7), 1454-1459, 2012
Krav: National Health and Medical Research Council, Australia
A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family
KE Ahmad, RL Davis, CM Sue
Journal of neurology 262, 2323-2328, 2015
Krav: National Health and Medical Research Council, Australia
Mutations in TUBB4A and spastic paraplegia
KR Kumar, F Vulinovic, K Lohmann, JS Park, S Schaake, CM Sue, C Klein
Movement Disorders 30 (13), 1857-1858, 2015
Krav: National Health and Medical Research Council, Australia, Research Foundation …
Hereditary parkinsonism-associated genetic variations in PARK9 locus Lead to functional impairment of ATPase type 13A2
C M. Sue, JS Park
Current Protein and Peptide Science 18 (7), 725-732, 2017
Krav: National Health and Medical Research Council, Australia
Strong predictive algorithm of pathogenesis-based biomarkers improves Parkinson’s disease diagnosis
DKY Chan, N Braidy, RF Chen, YH Xu, S Bentley, M Lubomski, RL Davis, ...
Molecular Neurobiology, 1-10, 2022
Krav: National Health and Medical Research Council, Australia
Axonal excitability during ischemia in MELAS
K Ng, KR Kumar, C Sue, D Burke
Muscle & Nerve 47 (5), 762-765, 2013
Krav: National Health and Medical Research Council, Australia
Tillgängliga någonstans: 100
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Krav: Swiss National Science Foundation, US National Institutes of Health, US …
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.